Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 111Carcinoma, Non-Small-Cell Lung 109Prostatic Neoplasms 96Multiple Myeloma 77Neoplasms 73Lung Neoplasms 66Leukemia, Myeloid, Acute 48Colorectal Neoplasms 48Neoplasm Metastasis 43Carcinoma, Renal Cell 39Pancreatic Neoplasms 38Melanoma 38Lymphoma 37Lymphoma, Non-Hodgkin 34Squamous Cell Carcinoma of Head and Neck 32Ovarian Neoplasms 32Leukemia, Lymphocytic, Chronic, B-Cell 31Urinary Bladder Neoplasms 29Hematologic Neoplasms 28Endometrial Neoplasms 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Carcinoma, Hepatocellular 25Triple Negative Breast Neoplasms 24Sarcoma 24Lymphoma, Follicular 24Lymphoma, Large B-Cell, Diffuse 23Head and Neck Neoplasms 23Glioma 23Uterine Cervical Neoplasms 22Stomach Neoplasms 22

Interventions

Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Liver Cirrhosis × 30 days × Clear all
NCT05044819 2026-06-01

Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution

Jazz Pharmaceuticals

Phase 4 Active not recruiting
154 enrolled

Epilepsies, Myoclonic, Liver Cirrhosis, Tuberous Sclerosis, Lennox Gastaut Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡